Erratum: Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy
β Scribed by Day, Sam E; Kettunen, Mikko I; Gallagher, Ferdia A; Hu, De-En; Lerche, Mathilde; Wolber, Jan; Golman, Klaes; Ardenkjaer-Larsen, Jan Henrik; Brindle, Kevin M
- Book ID
- 109932453
- Publisher
- Nature Publishing Group
- Year
- 2007
- Tongue
- English
- Weight
- 57 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1078-8956
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Measurements of early tumor responses to therapy have been shown, in some cases, to predict treatment outcome. We show in lymphoma-bearing mice injected intravenously with hyperpolarized [1-13 C]pyruvate that the lactate dehydrogenasecatalyzed flux of 13 C label between the carboxyl groups of pyruva
## Abstract We show here that hyperpolarized [1β^13^C]pyruvate can be used to detect treatment response in a glioma tumor model; a tumor type where detection of response with ^18^fluoroβ2βdeoxyglucose, using positron emission tomography, is limited by the high background signals from normal brain t
## Abstract Dynamic nuclear polarization can be used to increase the sensitivity of solution state ^13^C magnetic resonance spectroscopy by four orders of magnitude. We show here that [1β^13^C]glutamate can be polarized to 28%, representing a 35,000βfold increase in its sensitivity to detection at